ABCA1在高脂血症家兔颈动脉内皮中的过表达调控血管炎症。

IF 3.9 3区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Bradley K Wacker, Lianxiang Bi, Goren Saenz-Pipaon, Nicole Sanford, Abigail Z Regan, Natalie S Lim, Li Liu, Francis Kim, David A Dichek
{"title":"ABCA1在高脂血症家兔颈动脉内皮中的过表达调控血管炎症。","authors":"Bradley K Wacker, Lianxiang Bi, Goren Saenz-Pipaon, Nicole Sanford, Abigail Z Regan, Natalie S Lim, Li Liu, Francis Kim, David A Dichek","doi":"10.1089/hum.2024.166","DOIUrl":null,"url":null,"abstract":"<p><p>Endothelial activation and dysfunction are key early steps in atherogenesis. Vascular gene therapy targeting endothelial inflammation and cholesterol accumulation could decrease atherosclerosis progression. ATP-binding cassette subfamily A member 1 (ABCA1) exhibits anti-inflammatory properties and promotes cholesterol efflux. A mouse model showed that systemic endothelial overexpression of ABCA1 decreased diet-induced atherosclerosis. To test if local ABCA1 endothelial overexpression protects against atherosclerosis, we used helper-dependent adenoviral vectors (HDAd) to express ABCA1 or a \"Null\" control in the carotid endothelium of hyperlipidemic rabbits. Both <i>ABCA1</i> mRNA and endothelial protein were increased 3 days after vector infusion. After 24 weeks on a high-fat diet, laser-microdissected endothelium showed increased <i>ABCA1</i> mRNA expression, but whole-vessel <i>ABCA1</i> mRNA was decreased with HDAdABCA1. Endothelial ABCA1 protein could not be measured at 24 weeks, so its overexpression may be transient. <i>CD68</i> expression was decreased (-23%, <i>p</i> < 0.001), but <i>ITGAM</i> (-15%, <i>p</i> = 0.3) was unchanged. Macrophage markers for both M1-like macrophages (<i>IL1B</i>: -44% [<i>p</i> = 0.02]; <i>IL6</i>: -40% [<i>p</i> = 0.02]; <i>CCL2</i>: -25% [<i>p</i> = 0.02]) and M2-like macrophages (<i>ARG1</i>: -27% [<i>p</i> = 0.03]; <i>IL10</i>: -23% [<i>p</i> = 0.09]; <i>TGFB1</i>: -13% [<i>p</i> < 0.001]) were also decreased. The inflammatory cytokines <i>IL6</i> (-100%; <i>p</i> < 0.001) and <i>TNF</i> (<i>p</i> < 0.05) were significantly decreased in the laser-microdissected endothelium, but <i>VCAM1</i> (+5%, <i>p</i> = 1.0) was unchanged and <i>ICAM1</i> (+101%; <i>p</i> = 0.03) increased. Lesion size, intimal lipid, and intimal macrophage content were all unchanged (<i>p</i> > 0.5 for all), and vascular cholesterol measured by mass spectrometry (-11%; <i>p</i> = 0.9) also showed no difference. There was a small decrease in the intimal/medial ratio. scRNAseq revealed that vector transcripts were not restricted to endothelial cells after 24+ weeks but were detected in most cell types. The exception was modulated smooth muscle cells, which were found in substantial numbers in larger lesions. Overall, transient overexpression of ABCA1 in the vascular endothelium subtly alters the expression of inflammatory markers, providing only a modest atheroprotection.</p>","PeriodicalId":13007,"journal":{"name":"Human gene therapy","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation.\",\"authors\":\"Bradley K Wacker, Lianxiang Bi, Goren Saenz-Pipaon, Nicole Sanford, Abigail Z Regan, Natalie S Lim, Li Liu, Francis Kim, David A Dichek\",\"doi\":\"10.1089/hum.2024.166\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Endothelial activation and dysfunction are key early steps in atherogenesis. Vascular gene therapy targeting endothelial inflammation and cholesterol accumulation could decrease atherosclerosis progression. ATP-binding cassette subfamily A member 1 (ABCA1) exhibits anti-inflammatory properties and promotes cholesterol efflux. A mouse model showed that systemic endothelial overexpression of ABCA1 decreased diet-induced atherosclerosis. To test if local ABCA1 endothelial overexpression protects against atherosclerosis, we used helper-dependent adenoviral vectors (HDAd) to express ABCA1 or a \\\"Null\\\" control in the carotid endothelium of hyperlipidemic rabbits. Both <i>ABCA1</i> mRNA and endothelial protein were increased 3 days after vector infusion. After 24 weeks on a high-fat diet, laser-microdissected endothelium showed increased <i>ABCA1</i> mRNA expression, but whole-vessel <i>ABCA1</i> mRNA was decreased with HDAdABCA1. Endothelial ABCA1 protein could not be measured at 24 weeks, so its overexpression may be transient. <i>CD68</i> expression was decreased (-23%, <i>p</i> < 0.001), but <i>ITGAM</i> (-15%, <i>p</i> = 0.3) was unchanged. Macrophage markers for both M1-like macrophages (<i>IL1B</i>: -44% [<i>p</i> = 0.02]; <i>IL6</i>: -40% [<i>p</i> = 0.02]; <i>CCL2</i>: -25% [<i>p</i> = 0.02]) and M2-like macrophages (<i>ARG1</i>: -27% [<i>p</i> = 0.03]; <i>IL10</i>: -23% [<i>p</i> = 0.09]; <i>TGFB1</i>: -13% [<i>p</i> < 0.001]) were also decreased. The inflammatory cytokines <i>IL6</i> (-100%; <i>p</i> < 0.001) and <i>TNF</i> (<i>p</i> < 0.05) were significantly decreased in the laser-microdissected endothelium, but <i>VCAM1</i> (+5%, <i>p</i> = 1.0) was unchanged and <i>ICAM1</i> (+101%; <i>p</i> = 0.03) increased. Lesion size, intimal lipid, and intimal macrophage content were all unchanged (<i>p</i> > 0.5 for all), and vascular cholesterol measured by mass spectrometry (-11%; <i>p</i> = 0.9) also showed no difference. There was a small decrease in the intimal/medial ratio. scRNAseq revealed that vector transcripts were not restricted to endothelial cells after 24+ weeks but were detected in most cell types. The exception was modulated smooth muscle cells, which were found in substantial numbers in larger lesions. Overall, transient overexpression of ABCA1 in the vascular endothelium subtly alters the expression of inflammatory markers, providing only a modest atheroprotection.</p>\",\"PeriodicalId\":13007,\"journal\":{\"name\":\"Human gene therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human gene therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/hum.2024.166\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human gene therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/hum.2024.166","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

内皮细胞激活和功能障碍是动脉粥样硬化发生的关键早期步骤。针对内皮炎症和胆固醇积累的血管基因治疗可以减少动脉粥样硬化的进展。atp结合盒亚家族A成员1 (ABCA1)具有抗炎特性并促进胆固醇外排。小鼠模型显示,全身内皮过度表达ABCA1可减少饮食诱导的动脉粥样硬化。为了测试局部ABCA1内皮过表达是否能预防动脉粥样硬化,我们使用辅助依赖腺病毒载体(HDAd)在高脂血症兔子的颈动脉内皮中表达ABCA1或“零”对照。ABCA1 mRNA和内皮蛋白在载体输注3天后均升高。高脂饮食24周后,激光显微解剖内皮细胞显示ABCA1 mRNA表达增加,但全血管ABCA1 mRNA表达随着HDAdABCA1而降低。内皮ABCA1蛋白在24周时无法测量,因此其过表达可能是短暂的。CD68表达降低(-23%,p < 0.001),而ITGAM表达不变(-15%,p = 0.3)。m1样巨噬细胞的巨噬细胞标志物(il - 1b: -44% [p = 0.02];il - 6: -40% [p = 0.02];CCL2: -25% [p = 0.02])和m2样巨噬细胞(ARG1: -27% [p = 0.03];il - 10: -23% [p = 0.09];TGFB1: -13% [p < 0.001])也降低。炎性细胞因子IL6 (-100%;p < 0.001)和TNF (p < 0.05)显著降低,但VCAM1 (+5%, p = 1.0)不变,ICAM1 (+101%;P = 0.03)增高。病变大小、内膜脂质和内膜巨噬细胞含量均未改变(p < 0.05),质谱法测量血管胆固醇(-11%;P = 0.9)也无差异。内膜/内侧比值略有下降。scRNAseq显示,24周以上后,载体转录本不局限于内皮细胞,而是在大多数细胞类型中检测到。唯一的例外是调节平滑肌细胞,在较大的病变中发现了大量的平滑肌细胞。总的来说,血管内皮中ABCA1的短暂过表达微妙地改变了炎症标志物的表达,仅提供适度的动脉粥样硬化保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation.

Endothelial activation and dysfunction are key early steps in atherogenesis. Vascular gene therapy targeting endothelial inflammation and cholesterol accumulation could decrease atherosclerosis progression. ATP-binding cassette subfamily A member 1 (ABCA1) exhibits anti-inflammatory properties and promotes cholesterol efflux. A mouse model showed that systemic endothelial overexpression of ABCA1 decreased diet-induced atherosclerosis. To test if local ABCA1 endothelial overexpression protects against atherosclerosis, we used helper-dependent adenoviral vectors (HDAd) to express ABCA1 or a "Null" control in the carotid endothelium of hyperlipidemic rabbits. Both ABCA1 mRNA and endothelial protein were increased 3 days after vector infusion. After 24 weeks on a high-fat diet, laser-microdissected endothelium showed increased ABCA1 mRNA expression, but whole-vessel ABCA1 mRNA was decreased with HDAdABCA1. Endothelial ABCA1 protein could not be measured at 24 weeks, so its overexpression may be transient. CD68 expression was decreased (-23%, p < 0.001), but ITGAM (-15%, p = 0.3) was unchanged. Macrophage markers for both M1-like macrophages (IL1B: -44% [p = 0.02]; IL6: -40% [p = 0.02]; CCL2: -25% [p = 0.02]) and M2-like macrophages (ARG1: -27% [p = 0.03]; IL10: -23% [p = 0.09]; TGFB1: -13% [p < 0.001]) were also decreased. The inflammatory cytokines IL6 (-100%; p < 0.001) and TNF (p < 0.05) were significantly decreased in the laser-microdissected endothelium, but VCAM1 (+5%, p = 1.0) was unchanged and ICAM1 (+101%; p = 0.03) increased. Lesion size, intimal lipid, and intimal macrophage content were all unchanged (p > 0.5 for all), and vascular cholesterol measured by mass spectrometry (-11%; p = 0.9) also showed no difference. There was a small decrease in the intimal/medial ratio. scRNAseq revealed that vector transcripts were not restricted to endothelial cells after 24+ weeks but were detected in most cell types. The exception was modulated smooth muscle cells, which were found in substantial numbers in larger lesions. Overall, transient overexpression of ABCA1 in the vascular endothelium subtly alters the expression of inflammatory markers, providing only a modest atheroprotection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Human gene therapy
Human gene therapy 医学-生物工程与应用微生物
CiteScore
6.50
自引率
4.80%
发文量
131
审稿时长
4-8 weeks
期刊介绍: Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信